植物提取物是指从天然植物中经过物理、化学或生物技术方法提取出的有效成分或活性物质的统称。这些植物主要来源于陆地和海洋中的各种植物,包括草本植物、灌木、树木以及藻类等。
提取方法随着科学技术的进步,植物提取物的研究与应用日益广泛。研究人员不仅致力于提高提取效率和纯度,还积极探索新的分离技术及组分鉴定方法,以更好地揭示其化学成分及其生物学效应。
挑战与前景尽管植物提取物具有巨大的市场潜力和发展空间,但在实际应用中仍面临诸多挑战,如有效成分的稳定性和安全性问题、标准体系不完善等。未来的研究需要更加注重综合评价和合理利用天然资源,以促进该领域的可持续发展。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | quercetagetin 7-O-glucopyranoside | 548-75-4 | C21H20O13 |
|
—— | Quercetin-3-β-gentiobiosid | 7431-83-6 | C27H30O17 |
|
—— | cynarasaponin H | 98474-74-9 | C47H74O18 |
|
—— | (9E,11E)-13-oxooctadeca-9,11-dienoic acid | 29623-29-8 | C18H30O3 |
|
—— | 6α-O-β-D-glucopyranosyl-(20S,24R)-epoxydammarane-3β,12β,25-triol | 98474-78-3 | C36H62O10 |
|
—— | Coniferin | 531-29-3 | C16H22O8 |
|
—— | polygalacin D | 66663-91-0 | C57H92O27 |
|
—— | acacetin 7-O-glucoside | 4291-60-5 | C22H22O10 |
|
—— | gypsogenin-3-O-glucuronide | 96553-02-5 | C37H56O10 |
|
—— | gypsogenin | 639-14-5 | C30H46O4 |
|
—— | Toralactone 9-O-beta-D-gentiobioside | 119170-52-4 | C27H32O15 |
|
—— | cantleyoside | 32455-46-2 | C33H46O19 |
|
—— | Naringenin 7-O-glucuronide | 158196-34-0 | C21H20O11 |
|
—— | 2',4',6',4-Tetrahydroxychalcon | 25515-46-2 | C15H12O5 |
|
—— | 13-oxyingenol-dodecanoate | 54706-70-6 | C32H50O7 |
|
—— | soya-cerebroside II | 115074-93-6 | C40H75NO9 |
|
—— | [2'R-{2'α,3'aα,4'β,7'aα}]-7'a-{β-D-glucopyranosyloxy}-1',3'a,4',7'a-tetrahydro-4'-hydroxy-2',4',6'-trimethyl-spiro[cyclopropane-1-5'-{5H}inden-3'{2'H}-one] | 87625-62-5 | C20H30O8 |
|
—— | ptaquiloside | 87625-62-5 | C20H30O8 |
|
—— | Quercetin-3-O-beta-glucopyranosyl-7-O-alpha-rhamnopyranoside | 18016-58-5 | C27H30O16 |
|
—— | quercetin 3-O-β-D-galactoside-7-O-α-L-rhamnoside | 18016-58-5 | C27H30O16 |
|
—— | petiolaroside | 18016-58-5 | C27H30O16 |
|
—— | Flavonolglycosid C | 18016-58-5 | C27H30O16 |
|
—— | 2"-O-acetylsaikosaponin a | 102934-42-9 | C44H70O14 |
|
—— | 3-hydroxy-17-[(E)-6-hydroxy-6-methylhept-4-en-2-yl]-4,4,13,14-tetramethyl-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-9-carbaldehyde | 81348-83-6 | C36H58O9 |
|
—— | Chrysin-7-β-D-glucuronid | 35775-49-6 | C21H18O10 |
|
—— | rosiridin | 100462-37-1 | C16H28O7 |
|
—— | δ-tocopherol | 119-13-1 | C27H46O2 |
|
—— | methyl (2Z)-3-(3,4,5-trimethoxyphenyl)acrylate | 7560-49-8 | C13H16O5 |
|
—— | Totarol | 511-15-9 | C20H30O |
|
—— | (+/-)-totarol | 511-15-9 | C20H30O |
|
—— | beta-D-Glucopyranoside, (3beta,6alpha,16beta,24R)-3-[(2,3-di-O-acetyl-beta-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl | 91739-00-3 | C45H72O16 |
|
—— | (3R,8S)-falcarindiol | 225110-25-8 | C17H24O2 |
|
—— | kamebakaurin A | 73981-34-7 | C20H30O5 |
|
—— | (2S,3R,4S,5S,6R)-2-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2E)-3-(4-hydroxyphenyl)prop-2-enoate | 59282-55-2 | C30H26O12 |
|
—— | 1-(3,4-Dihydroxycinnamoyl)quinic acid | 1241-87-8 | C16H18O9 |
|
—— | N-cis-caffeoyl putrescine | 29554-26-5 | C13H18N2O3 |
|
—— | Neoherculin | 504-97-2 | C16H25NO |
|
—— | (+)-Soyacerebroside I | 114297-20-0 | C40H75NO9 |
|
—— | 7b-Hydroxy-3,11,15,23-tetraoxolanosta-8,20(22)-dien-26-oic acid | 100665-43-8 | C30H40O7 |
|
—— | 3b,7b-Dihydroxy-11,15,23-trioxolanosta-8,20(22)E-dien-26-oic acid | 100665-41-6 | C30H42O7 |
|
—— | Ganoderenic acid E | 110241-23-1 | C30H40O8 |
|
—— | 2''-O-p-Coumaroylvitexin | 59282-55-2 | C30H26O12 |
|
—— | 2-(hydroxymethyl)-6-[[12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2Z)-6-methylhepta-2,5-dien-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol | 105558-26-7 | C36H60O7 |
|
—— | (+)-Ginsenoside Rh4 | 174721-08-5 | C36H60O8 |
|
—— | [(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4R,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl] (1S,2R,4aS,6aR,6aS,6bR,8aR,9R,10R,11R,12aR,14bR)-10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylate | 16830-15-2 | C48H78O19 |
|
—— | galgravin | 528-63-2 | C22H28O5 |
|
—— | methyl 2-[(1R,2S,4R,9R,10S,11R,15R)-6-(furan-3-yl)-7,9,11,15-tetramethyl-12,16-dioxo-3,17-dioxapentacyclo[9.6.1.02,9.04,8.015,18]octadeca-7,13-dien-10-yl]acetate | 25990-37-8 | C27H30O7 |
|
—— | 6-deoxy-beta-D-glucopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->6)-1-O-[(2alpha,3alpha,5xi,9xi)-2,3,23-trihydroxy-28-oxours-12-en-28-yl]-alpha-L-mannopyranose | 16830-15-2 | C48H78O19 |
|
—— | (1aR,2S,5R,5aR,6S,8aS,9R,10aR)-1a,2,5,5a,6,9,10,10a-Octahydro-5,5a,6-trihydroxy-4-(hydroxymethyl)-1,1,7,9-tetramethyl-1H-2,8a-methanocyclopenta[a]cyclopropa[e]cyclodecen-11-one | 30220-46-3 | C20H28O5 |
|
—— | [(2S,4R,5S)-6-[[(2R,4S,5S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl] (1S,2R,6aR,6aS,6bR,9R,10R,11R,12aR,14bS)-10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylate | 16830-15-2 | C48H78O19 |
|